ECRIN’s French National Partner, F-CRIN, Co-Organising Training on Orphan Drugs & Rare Diseases

4 October 2016

Eudipharm, OrphanDev and ECRIN’s French national partner, F-CRIN, have teamed up to organise a training session on orphan drugs and rare diseases. The event will be held from 17 to 18 November 2016 in Marseille, France.

The seminar aims to raise awareness among clinical research actors of the specificities of drug development for rare diseases. The first day will be focused on regulatory issues and the second day on drug repositioning and personalised medicine. Presentations will be made by clinical research experts and authorities.

Access the program here

Learn more about the training session on the F-CRIN website [page in French]

About the Organisers

F-CRIN is ECRIN’s French national scientific partner. It was created to reinforce French competitiveness in regards to clinical research, and supports investigators and sponsors at every stage of clinical development. F-CRIN focuses on proof-of-concept studies, multinational clinical trials, and projects submitted to European calls. Learn more:

Eudipahrm is a master’s degree in pharmaceutical medicine offered by Université Claude Bernard in Lyon, France. Learn more:

OrphanDev is a component of F-CRIN that provides support for clinical trial projects on rare diseases, working with institutions, academics, and drug companies. Learn more: